There are so many factors that would undermine his chances for success.

It's hard for me to imagine a Latin American country cutting off its nose to spite its face.

There is a sort of blurring of the lines from the perspective of the US security establishment.

The left in 2006 in Latin America is far different than in 1976.

Drug stocks have remained relatively cheap, and you'll notice that since interest rates are of little importance to the major pharmaceutical companies ... there's a run toward some of the defensive characteristics of drug stocks.

We're dealing with the courts, and lots of unfortunate mistakes come in trying to divine what the courts will do. Both companies are facing something only a few weeks away; it could be good or bad for either.